These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24263146)

  • 1. Prevalence and correlates of metabolic syndrome in patients with rheumatoid arthritis in Argentina.
    Salinas MJ; Bertoli AM; Lema L; Saucedo C; Rosa J; Quintana R; Bellomio V; Agüero S; Spindler W; Tamborenea N; Schimid M; Ceccato F; Sala JP; Paira S; Spindler A; Soriano ER; Estel BA; Caeiro F; Alvarellos A; Saurit V
    J Clin Rheumatol; 2013 Dec; 19(8):439-43. PubMed ID: 24263146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome prevalence is increased in rheumatoid arthritis patients and is associated with disease activity.
    da Cunha VR; Brenol CV; Brenol JC; Fuchs SC; Arlindo EM; Melo IM; Machado CA; de Castro Chaves H; Xavier RM
    Scand J Rheumatol; 2012 May; 41(3):186-91. PubMed ID: 22416768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: a population-based study.
    Bener A; Zirie M; Musallam M; Khader YS; Al-Hamaq AO
    Metab Syndr Relat Disord; 2009 Jun; 7(3):221-9. PubMed ID: 19320557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and factors associated with metabolic syndrome in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Zonana-Nacach A; Santana-Sahagún E; Jiménez-Balderas FJ; Camargo-Coronel A
    J Clin Rheumatol; 2008 Apr; 14(2):74-7. PubMed ID: 18391674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study.
    Karvounaris SA; Sidiropoulos PI; Papadakis JA; Spanakis EK; Bertsias GK; Kritikos HD; Ganotakis ES; Boumpas DT
    Ann Rheum Dis; 2007 Jan; 66(1):28-33. PubMed ID: 16793841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome: prevalence, associated factors, and C-reactive protein: the MADRIC (MADrid RIesgo Cardiovascular) Study.
    Martínez MA; Puig JG; Mora M; Aragón R; O'Dogherty P; Antón JL; Sánchez-Villares T; Rubio JM; Rosado J; Torres R; Marcos J; Pallardo LF; Banegas JR;
    Metabolism; 2008 Sep; 57(9):1232-40. PubMed ID: 18702949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence of dyslipidemia and elevated cardiovascular risk in patients with rheumatoid arthritis].
    Haye Salinas MJ; Bertoli AM; Lema L; Saucedo C; Rosa J; Quintana R; Bellomio V; Aguero S; Spindler W; Tamborenea MN; Schimid M; Ceccato F; Sala JP; Paira S; Spindler A; Soriano ER; Estel BA; Caeiro F; Alvarellos A; Saurit V
    Medicina (B Aires); 2013; 73(1):26-30. PubMed ID: 23335702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
    Fiuza M; Cortez-Dias N; Martins S; Belo A;
    Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of HLA-DRB1 alleles with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in northern east part of Turkey.
    Uçar F; Çapkin E; Karkucak M; Yücel B; Sönmez M; Alver A; Kaklikkaya N; Tosun M; Alemdaroğlu E; Solak M
    Int J Rheum Dis; 2012 Dec; 15(6):538-45. PubMed ID: 23253237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status.
    Bang SY; Lee KH; Cho SK; Lee HS; Lee KW; Bae SC
    Arthritis Rheum; 2010 Feb; 62(2):369-77. PubMed ID: 20112396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperhomocysteinemia, coronary heart disease, and diabetes mellitus as predicted by various definitions for metabolic syndrome in a hypertensive Saudi population.
    Al-Daghri NM
    Saudi Med J; 2007 Mar; 28(3):339-46. PubMed ID: 17334456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IDF and ATP-III definitions of metabolic syndrome in the prediction of all-cause mortality in type 2 diabetic patients.
    Monami M; Marchionni N; Masotti G; Mannucci E
    Diabetes Obes Metab; 2007 May; 9(3):350-3. PubMed ID: 17391162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations.
    Korkmaz C; Us T; Kaşifoğlu T; Akgün Y
    Clin Biochem; 2006 Oct; 39(10):961-5. PubMed ID: 16979149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis.
    Mok CC; Ko GT; Ho LY; Yu KL; Chan PT; To CH
    Arthritis Care Res (Hoboken); 2011 Feb; 63(2):195-202. PubMed ID: 20890981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis.
    López-Longo FJ; Oliver-Miñarro D; de la Torre I; González-Díaz de Rábago E; Sánchez-Ramón S; Rodríguez-Mahou M; Paravisini A; Monteagudo I; González CM; García-Castro M; Casas MD; Carreño L
    Arthritis Rheum; 2009 Apr; 61(4):419-24. PubMed ID: 19333979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the new International Diabetes Federation definition of metabolic syndrome improve prediction of coronary artery disease and carotid intima-media thickening?
    Timóteo A; Santos R; Lima S; Mamede A; Fernandes R; Ferreira R
    Rev Port Cardiol; 2009 Feb; 28(2):173-81. PubMed ID: 19438152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.
    Rantapää-Dahlqvist S; de Jong BA; Berglin E; Hallmans G; Wadell G; Stenlund H; Sundin U; van Venrooij WJ
    Arthritis Rheum; 2003 Oct; 48(10):2741-9. PubMed ID: 14558078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of vascular disease in metabolic syndrome using three proposed definitions.
    Athyros VG; Ganotakis ES; Elisaf MS; Liberopoulos EN; Goudevenos IA; Karagiannis A;
    Int J Cardiol; 2007 Apr; 117(2):204-10. PubMed ID: 16854482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of metabolic syndrome in adults with excess of adiposity: comparison of the Adult Treatment Panel III criteria with the International Diabetes Federation definition.
    González-Ortiz M; Martínez-Abundis E; Jacques-Camarena O; Hernández-González SO; Valera-González IG; Ramos-Zavala MG
    Acta Diabetol; 2006 Nov; 43(3):84-6. PubMed ID: 17143786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study.
    Hildrum B; Mykletun A; Hole T; Midthjell K; Dahl AA
    BMC Public Health; 2007 Aug; 7():220. PubMed ID: 17727697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.